The stock of Genesis Healthcare Inc (NYSE:GEN) is a huge mover today! The stock increased 4.10% or $0.11 during the last trading session, hitting $2.79. About 166,253 shares traded hands. Genesis Healthcare Inc (NYSE:GEN) has risen 50.00% since February 29, 2016 and is uptrending. It has outperformed by 37.78% the S&P500.
The move comes after 7 months positive chart setup for the $439.11M company. It was reported on Oct, 4 by Barchart.com. We have $7.11 PT which if reached, will make NYSE:GEN worth $680.62 million more.
Analysts await Genesis Healthcare Inc (NYSE:GEN) to report earnings on November, 3. They expect $-0.01 earnings per share, down 114.29% or $0.08 from last year’s $0.07 per share. After $0.06 actual earnings per share reported by Genesis Healthcare Inc for the previous quarter, Wall Street now forecasts -116.67% negative EPS growth.
Genesis Healthcare Inc (NYSE:GEN) Ratings Coverage
Out of 4 analysts covering Genesis Healthcare (NYSE:GEN), 1 rate it a “Buy”, 2 “Sell”, while 1 “Hold”. This means 25% are positive. Genesis Healthcare has been the topic of 8 analyst reports since August 10, 2015 according to StockzIntelligence Inc. The stock of Genesis Healthcare Inc (NYSE:GEN) earned “Sell” rating by UBS on Monday, February 8. The stock of Genesis Healthcare Inc (NYSE:GEN) has “Outperform” rating given on Monday, May 16 by RBC Capital Markets. RBC Capital Markets upgraded the stock to “Sector Perform” rating in Monday, August 10 report. The rating was maintained by Susquehanna on Tuesday, January 26 with “Neutral”. RBC Capital Markets maintained Genesis Healthcare Inc (NYSE:GEN) on Tuesday, January 26 with “Outperform” rating. The company was maintained on Monday, November 9 by UBS. The firm earned “Neutral” rating on Tuesday, January 26 by Bank of America. Bank of America downgraded the shares of GEN in a report on Monday, May 16 to “Underperform” rating.
According to Zacks Investment Research, “Genesis Healthcare, Inc. provides long-term care, assisted/senior living and rehabilitation therapy. Genesis Healthcare, Inc., formerly known as Skilled Healthcare Group, Inc., is based in Kennett Square, Pennsylvania.”
More notable recent Genesis Healthcare Inc (NYSE:GEN) news were published by: Prnewswire.com which released: “Genesis HealthCare Makes Significant Headway In Capital Strengthening Initiatives” on August 01, 2016, also Prnewswire.com with their article: “Genesis HealthCare Signs Agreement To Sell Home Health And Hospice Operations” published on March 09, 2016, Prnewswire.com published: “Genesis HealthCare To Acquire 24 Skilled Nursing Facilities From Revera Inc.” on June 15, 2015. More interesting news about Genesis Healthcare Inc (NYSE:GEN) were released by: Prnewswire.com and their article: “Genesis HealthCare Reports First Quarter 2016 Results” published on May 09, 2016 as well as Philly.com‘s news article titled: “Genesis Healthcare in $52.7M settlement with U.S.” with publication date: August 01, 2016.
GEN Company Profile
Genesis Healthcare, Inc., formerly Skilled Healthcare Group, Inc., incorporated on October 21, 2005, is a holding firm that provides post-acute care. The Firm operates through three divisions: inpatient services, which includes the operation of skilled nursing facilities and assisted or senior living facilities; rehabilitation therapy services, which includes its integrated and third-party rehabilitation and respiratory therapy services, and all other services. It offers inpatient services through its network of over 500 skilled nursing and assisted/senior living facilities in 34 states, consisting of over 475 skilled nursing facilities and over 35 stand-alone assisted/senior living facilities. The Company’s skilled nursing and assisted/senior living facilities have over 61,000 licensed beds, with its states of operation in California, Maryland, Massachusetts, New Jersey, and Pennsylvania. The Company’s services focus primarily on the medical and physical issues facing elderly patients and are provided by its skilled nursing companies, assisted or senior living communities, integrated and third-party rehabilitation therapy business, and other ancillary services.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.